| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.1 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.24 | 0.1 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.084 | 0.1 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |